Literature DB >> 24602085

Gastrointestinal morbidity in obesity.

Andres Acosta1, Michael Camilleri.   

Abstract

Obesity is a complex disease that results from increased energy intake and decreased energy expenditure. The gastrointestinal system plays a key role in the pathogenesis of obesity and facilitates caloric imbalance. Changes in gastrointestinal hormones and the inhibition of mechanisms that curtail caloric intake result in weight gain. It is not clear if the gastrointestinal role in obesity is a cause or an effect of this disease. Obesity is often associated with type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Obesity is also associated with gastrointestinal disorders, which are more frequent and present earlier than T2DM and CVD. Diseases such as gastroesophageal reflux disease (GERD), cholelithiasis, or nonalcoholic steatohepatitis are directly related to body weight and abdominal adiposity. Our objective is to assess the role of each gastrointestinal organ in obesity and the gastrointestinal morbidity resulting in those organs from the effects of obesity.
© 2014 New York Academy of Sciences.

Entities:  

Keywords:  GERD; appetite; cancer; diarrhea; gastrointestinal; obesity

Mesh:

Year:  2014        PMID: 24602085      PMCID: PMC4122663          DOI: 10.1111/nyas.12385

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  162 in total

Review 1.  Recent advances in clinical practice challenges and opportunities in the management of obesity.

Authors:  Andres Acosta; Barham K Abu Dayyeh; John D Port; Michael Camilleri
Journal:  Gut       Date:  2014-01-08       Impact factor: 23.059

Review 2.  Control of food intake in the obese.

Authors:  J E Blundell; A Gillett
Journal:  Obes Res       Date:  2001-11

3.  Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity.

Authors:  M I Vazquez-Roque; M Camilleri; A Vella; P Carlson; J Laugen; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-04-07       Impact factor: 3.598

4.  Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study.

Authors:  George N Ioannou; Noel S Weiss; Kris V Kowdley; Jason A Dominitz
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

5.  Effect of different macronutrients in excess on gastric sensory and motor functions and appetite in normal-weight, overweight, and obese humans.

Authors:  Moo In Park; Michael Camilleri; Helen O'Connor; Lavonne Oenning; Duane Burton; Debra Stephens; Alan R Zinsmeister
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

Review 6.  Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease.

Authors:  N L De Groot; J S Burgerhart; P C Van De Meeberg; D R de Vries; A J P M Smout; P D Siersema
Journal:  Aliment Pharmacol Ther       Date:  2009-09-16       Impact factor: 8.171

7.  Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.

Authors:  Jun Seok Lee; Sang Heum Kim; Dae Won Jun; Jee Hye Han; Eun Chul Jang; Ji Young Park; Byung Kwan Son; Seong Hwan Kim; Yoon Ju Jo; Young Sook Park; Yong Soo Kim
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

8.  Central adiposity, regional fat distribution, and the risk of cholecystectomy in women.

Authors:  C-J Tsai; M F Leitzmann; W C Willett; E L Giovannucci
Journal:  Gut       Date:  2006-02-14       Impact factor: 23.059

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

Review 10.  Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.

Authors:  Seung-Hoi Koo
Journal:  Clin Mol Hepatol       Date:  2013-09-30
View more
  10 in total

1.  Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.

Authors:  Xiaoyun Feng; Cuiling Zhu; Sojin Lee; Jingyang Gao; Ping Zhu; Jun Yamauchi; Chenglin Pan; Sucha Singh; Shen Qu; Rita Miller; Satdarshan P Monga; Yongde Peng; H Henry Dong
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

Review 2.  Bariatric and metabolic surgery: a shift in eligibility and success criteria.

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2015-06-09       Impact factor: 43.330

3.  A working paradigm for the treatment of obesity in gastrointestinal practice.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Tech Gastrointest Endosc       Date:  2017-01-25

4.  Improving residents' clinical approach to obesity: impact of a multidisciplinary didactic curriculum.

Authors:  Andres Acosta; Alice Azzalin; Claudia J Emmons; Jonathan J Shuster; Melanie Jay; Margaret C Lo
Journal:  Postgrad Med J       Date:  2014-09-11       Impact factor: 2.401

5.  PREVALENCE AND PREDICTORS OF CHANGES IN BOWEL HABITS AFTER LAPAROSCOPIC CHOLECYSTECTOMY.

Authors:  Leonardo de Mello Del Grande; Luis Fernando Paes Leme; Francisco Pimenta Marques; Andressa Teruya Ramos; Paula Teruya Ramos; Felipe Araújo de Souza
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

6.  Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.

Authors:  Seung Eun Jung; Nam Seok Joo; Kyung Sun Han; Kyu Nam Kim
Journal:  J Korean Med Sci       Date:  2017-06       Impact factor: 2.153

7.  Lifestyle factors and risk of sickness absence from work: a multicohort study.

Authors:  Marianna Virtanen; Jenni Ervasti; Jenny Head; Tuula Oksanen; Paula Salo; Jaana Pentti; Anne Kouvonen; Ari Väänänen; Sakari Suominen; Markku Koskenvuo; Jussi Vahtera; Marko Elovainio; Marie Zins; Marcel Goldberg; Mika Kivimäki
Journal:  Lancet Public Health       Date:  2018-11

Review 8.  Role of Non-pharmacological Interventions and Weight Loss in the Management of Gastroesophageal Reflux Disease in Obese Individuals: A Systematic Review.

Authors:  Maria Mukhtar; Mohammed J Alzubaidee; Raga Sruthi Dwarampudi; Sheena Mathew; Sumahitha Bichenapally; Vahe Khachatryan; Asmaa Muazzam; Chandani Hamal; Lakshmi Sai Deepak Reddy Velugoti; Godfrey Tabowei; Greeshma N Gaddipati; Safeera Khan
Journal:  Cureus       Date:  2022-08-31

9.  Is perceived intolerance to milk and wheat associated with the corresponding IgG and IgA food antibodies? A cross sectional study in subjects with morbid obesity and gastrointestinal symptoms.

Authors:  Anne Stine Kvehaugen; Dag Tveiten; Per G Farup
Journal:  BMC Gastroenterol       Date:  2018-01-30       Impact factor: 3.067

Review 10.  Inflammation and Gut-Brain Axis During Type 2 Diabetes: Focus on the Crosstalk Between Intestinal Immune Cells and Enteric Nervous System.

Authors:  Arnaud Bessac; Patrice D Cani; Etienne Meunier; Gilles Dietrich; Claude Knauf
Journal:  Front Neurosci       Date:  2018-10-10       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.